110 found
Order:
Disambiguations:
Rebecca Dresser [106]Rebecca S. Dresser [6]
  1.  40
    Rebecca Dresser (1995). Dworkin on Dementia: Elegant Theory, Questionable Policy. Hastings Center Report 25 (6):32-38.
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography   14 citations  
  2.  30
    Rebecca Dresser (2011). Bioethics and Cancer: When the Professional Becomes Personal. Hastings Center Report 41 (6):14-18.
    In 2006, I was diagnosed with cancer. This began a crash course in real-world medical ethics. Having cancer was awful, but it was instructive, too. The experience gave me a new understanding of what my profession is about. Individuals in the bioethics field often address topics related to cancer, such as medical decision-making, the patient-physician relationship, clinical trials, and access to health care. Yet few engaged in this work have lived with cancer themselves. Experience as a cancer patient or family (...)
    Direct download (9 more)  
     
    Export citation  
     
    My bibliography   5 citations  
  3.  4
    Rebecca Dresser (1992). Wanted. Hastings Center Report 22 (1):24-29.
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography   25 citations  
  4.  1
    Rebecca Dresser (2001). [Book Review] When Science Offers Salvation, Patient Advocacy and Research Ethics. [REVIEW] Hastings Center Report 31 (6):47-48.
    Direct download  
     
    Export citation  
     
    My bibliography   17 citations  
  5.  8
    Rebecca Dresser & Joel Frader (2009). Off-Label Prescribing: A Call for Heightened Professional and Government Oversight. Journal of Law, Medicine & Ethics 37 (3):476-486.
    Under current U.S. law, physicians may prescribe drugs and devices in situations not covered on the label approved by the Food and Drug Administration. Those supporting this system say that requiring FDA approval for off-label uses would unnecessarily impede the delivery of benefits to patients. Patients do benefit from off-label prescribing that is supported by sound scientific and medical evidence. In the absence of such evidence, however, off-label prescribing can expose patients to risky and ineffective treatments. The medical community and (...)
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   7 citations  
  6. Leili Fatehi, Susan M. Wolf, Jeffrey McCullough, Ralph Hall, Frances Lawrenz, Jeffrey P. Kahn, Cortney Jones, Stephen A. Campbell, Rebecca S. Dresser, Arthur G. Erdman, Christy L. Haynes, Robert A. Hoerr, Linda F. Hogle, Moira A. Keane, George Khushf, Nancy M. P. King, Efrosini Kokkoli, Gary Marchant, Andrew D. Maynard, Martin Philbert, Gurumurthy Ramachandran, Ronald A. Siegel & Samuel Wickline (2012). Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field. Journal of Law, Medicine and Ethics 40 (4):716-750.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography   4 citations  
  7.  4
    Rebecca Dresser (2015). Treatment Decisions and Changing Selves. Journal of Medical Ethics 41 (12):975-976.
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  8.  63
    Rebecca Dresser (2010). Stem Cell Research as Innovation: Expanding the Ethical and Policy Conversation. Journal of Law, Medicine & Ethics 38 (2):332-341.
    Research using human embryonic stem cells raises an array of complex ethical issues, including, but by no means limited to, the moral status of developing human life. Unfortunately much of the public discussion fails to take into account this complexity. Advocacy for liberal and conservative positions on human embryonic stem cell research can be simplistic and misleading. Ethical concepts such as truth-telling, scientific integrity, and social justice should be part of the debate over federal support for human embryonic stem cell (...)
    Direct download (5 more)  
     
    Export citation  
     
    My bibliography   3 citations  
  9.  14
    Rebecca Dresser (2002). The Ubiquity and Utility of the Therapeutic Misconception. Social Philosophy and Policy 19 (2):271-294.
    The term “therapeutic misconception” was coined in 1982 by Paul Appelbaum, Loren Roth, and Charles Lidz. Appelbaum and his colleagues interviewed participants in several psychiatric studies, including a drug trial with a placebo control arm. Appelbaum's group found that many people were unaware of the differences between participating in a study and receiving treatment in the clinical setting. Rather than understanding these differences, study participants tended to believe that therapy and research were governed by the same primary goal: to advance (...)
    Direct download (6 more)  
     
    Export citation  
     
    My bibliography   8 citations  
  10.  14
    Rebecca Dresser (2004). Plan B: Politics and Values at the FDA, Again. Hastings Center Report 34 (6):9.
    No categories
    Direct download  
     
    Export citation  
     
    My bibliography  
  11. Rebecca Dresser & Joel Frader (2009). Off-Label Prescribing: A Call for Heightened Professional and Government Oversight. Journal of Law, Medicine and Ethics 37 (3):476-486.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography   4 citations  
  12.  20
    Rebecca Dresser (2007). The Curious Case of Off-Label Use. Hastings Center Report 37 (3):9-11.
    Direct download (5 more)  
     
    Export citation  
     
    My bibliography   4 citations  
  13.  5
    Rebecca Dresser & Peter J. Whitehouse (1994). The Incompetent Patient on the Slippery Slope. Hastings Center Report 24 (4):6-12.
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography   9 citations  
  14.  11
    Rebecca Dresser (2013). Subversive Subjects: Rule‐Breaking and Deception in Clinical Trials. Journal of Law, Medicine & Ethics 41 (4):829-840.
    Research subjects do not always conform to research requirements. When their personal interests conflict with the demands of participation, some subjects surreptitiously break the rules. These subjects are subversive — they undermine the research endeavor. In rejecting the restrictions research imposes, subversive subjects diminish the value of research results. From one vantage point, subversive subjects engage in unethical behavior. They create risks to themselves and others; they also disregard ethical responsibilities to adhere to research agreements and tell the truth. At (...)
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  15. Rebecca Dresser (2012). Building an Ethical Foundation for First-in-Human Nanotrials. Journal of Law, Medicine and Ethics 40 (4):802-808.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  16. Rebecca Dresser (2010). Stem Cell Research as Innovation: Expanding the Ethical and Policy Conversation. Journal of Law, Medicine and Ethics 38 (2):332-341.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography   3 citations  
  17.  33
    Rebecca Dresser (2005). Professionals, Conformity, and Conscience. Hastings Center Report 35 (6):9-10.
    Direct download (7 more)  
     
    Export citation  
     
    My bibliography   3 citations  
  18.  59
    Rebecca S. Dresser & John A. Robertson (1989). Quality of Life and Non-Treatment Decisions for Incompetent Patients: A Critique of the Orthodox Approach. Journal of Law, Medicine & Ethics 17 (3):234-244.
  19.  15
    Rebecca Dresser (2010). Suicide Attempts and Treatment Refusals. Hastings Center Report 40 (3):10-11.
    Direct download (6 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  20. Rebecca Dresser (2009). First-in-Human Trial Participants: Not a Vulnerable Population, but Vulnerable Nonetheless. Journal of Law, Medicine and Ethics 37 (1):38-50.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography   3 citations  
  21.  20
    Rebecca Dresser (2006). Private-Sector Research Ethics: Marketing or Good Conflicts Management? The 2005 John J. Conley Lecture on Medical Ethics. [REVIEW] Theoretical Medicine and Bioethics 27 (2):115-139.
    Pharmaceutical companies are major sponsors of biomedical research. Most scholars and policymakers focus their attention on government and academic oversight activities, however. In this article, I consider the role of pharmaceutical companies’ internal ethics statements in guiding decisions about corporate research and development (R&D). I review materials from drug company websites and contributions from the business and medical ethics literature that address ethical responsibilities of businesses in general and pharmaceutical companies in particular. I discuss positive and negative uses of pharmaceutical (...)
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography   3 citations  
  22.  12
    Rebecca Dresser (2012). Building an Ethical Foundation for First-in-Human Nanotrials. Journal of Law, Medicine & Ethics 40 (4):802-808.
    Novel nanomedical interventions require human testing to evaluate their safety and effectiveness. To establish a proper evidentiary basis for human trials, nanomedical innovations must first be subjected to animal and other laboratory testing. But it is uncertain whether the traditional laboratory approaches to safety evaluation will supply adequate information on nanotechnology risks to humans. This uncertainty, together with other features of nanomedical innovation, heightens the ethical challenges in conducting FIH nanotrials.
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  23.  11
    Leili Fatehi, Susan M. Wolf, Jeffrey McCullough, Ralph Hall, Frances Lawrenz, Jeffrey P. Kahn, Cortney Jones, Stephen A. Campbell, Rebecca S. Dresser, Arthur G. Erdman, Christy L. Haynes, Robert A. Hoerr, Linda F. Hogle, Moira A. Keane, George Khushf, Nancy M. P. King, Efrosini Kokkoli, Gary Marchant, Andrew D. Maynard, Martin Philbert, Gurumurthy Ramachandran, Ronald A. Siegel & Samuel Wickline (2012). Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field. Journal of Law, Medicine & Ethics 40 (4):716-750.
    The nanomedicine field is fast evolving toward complex, “active,” and interactive formulations. Like many emerging technologies, nanomedicine raises questions of how human subjects research (HSR) should be conducted and the adequacy of current oversight, as well as how to integrate concerns over occupational, bystander, and environmental exposures. The history of oversight for HSR investigating emerging technologies is a patchwork quilt without systematic justification of when ordinary oversight for HSR is enough versus when added oversight is warranted. Nanomedicine HSR provides an (...)
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  24.  1
    Rebecca Dresser (2013). Drug Compounding, Drug Safety, and the First Amendment. Hastings Center Report 43 (2):9-10.
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  25. Randy Malamud, Jeffrey Moussaieff Masson, Ollin Eugene Myers Jr, Barbara Orlans, Tom L. Beauchamp, Rebecca Dresser, David B. Morton, John P. Gluck, Kenneth D. Pimple & F. Barbara Orlans (1997). Ralph H. Lutts The Wild Animal Story Philadelphia: Temple University Press, 1998, 302 Pp. Howard Lyman Mad Cowboy. [REVIEW] Ethics and Behavior 7:2.
     
    Export citation  
     
    My bibliography  
  26.  47
    Rebecca Dresser (2009). Irrational Basis: The Legal Status of Medical Marijuana. Hastings Center Report 39 (6):7-8.
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography  
  27.  3
    Rebecca Dresser (2009). First-in-Human Trial Participants: Not a Vulnerable Population, but Vulnerable Nonetheless. Journal of Law, Medicine & Ethics 37 (1):38-50.
    The 21st-century translational science campaign could lead to an increase in first-in-human trials. As tests of investigational interventions move from the laboratory to human research, scientists, officials, and review committees should address ongoing concerns about the ethics of FIH trials. In this article, I describe three ethical considerations relevant to all FIH trials: the requirement for adequate preclinical research; study design safeguards; and choice of subject population. I also examine specific ethical considerations relevant to the three subject populations involved in (...)
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  28.  34
    Rebecca Dresser (1988). Standards for Animal Research: Looking at the Middle. Journal of Medicine and Philosophy 13 (2):123-143.
    Much of the public debate over laboratory animal use has focused on either the scientist's demand for absolute freedom of inquiry, or the abolitionist's demand for an end to animal use in science. Yet many recent proposals for reform seek instead to balance the interests of laboratory animals in avoiding harm against the interests of research beneficiaries in continued animal use. This essay is an analysis of the intermediate reform positions and their underlying ethical principles. Keywords: animal research, animal experimentation, (...)
    Direct download (7 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  29.  48
    Rebecca Dresser (2007). Protecting Women From Their Abortion Choices. Hastings Center Report 37 (6):13-14.
    Direct download (5 more)  
     
    Export citation  
     
    My bibliography  
  30.  17
    Rebecca Dresser (2009). Prenatal Testing and Disability: A Truce in the Culture Wars? Hastings Center Report 39 (3):7-8.
    Direct download (5 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  31.  4
    Rebecca Dresser (2006). Investigational Drugs and the Constitution. Hastings Center Report 36 (6):9-10.
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  32. Rebecca Dresser (1989). Advance Directives, Self-Determination, and Personal Identity. In Chris Hackler, Ray Moseley & Dorothy E. Vawter (eds.), Advance Directives in Medicine. Praeger 155--70.
     
    Export citation  
     
    My bibliography   3 citations  
  33.  1
    Rebecca Dresser (2000). Regulating Assisted Reproduction. Hastings Center Report 30 (6):26-27.
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   3 citations  
  34.  30
    Rebecca Dresser (2011). Families and Forensic DNA Profiles. Hastings Center Report 41 (3):11-12.
    Law enforcement officials often turn to DNA identification methods to detect—and rule out—possible offenders. Every state operates its own database of convicted offenders' DNA profiles; some states store profiles of arrested people, too. The Federal Bureau of Investigation maintains a national database of profiles submitted by laboratories across the country.A few years ago, officials came up with a new way to use DNA profiles in forensic identification. Ordinary searches require an exact match between DNA found at a crime scene and (...)
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography  
  35.  33
    Rebecca Dresser (1984). Involuntary Confinement: Legal and Psychiatric Perspectives. Journal of Medicine and Philosophy 9 (3):295-300.
    Direct download (5 more)  
     
    Export citation  
     
    My bibliography  
  36.  22
    Rebecca Dresser (2005). A New Era in Drug Regulation? Hastings Center Report 35 (3):10-11.
    Direct download (7 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  37.  15
    Rebecca Dresser (2008). The Limits of Apology Laws. Hastings Center Report 38 (3):pp. 6-7.
    Direct download (7 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  38.  11
    Rebecca Dresser (2005). Schiavo's Legacy: The Need for an Objective Standard. Hastings Center Report 35 (3):20-22.
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography  
  39.  28
    Rebecca Dresser (2005). Stem Cell Research: The Bigger Picture. Perspectives in Biology and Medicine 48 (2):181-194.
  40.  29
    Rebecca Dresser (2009). Substituting Authenticity for Autonomy. Hastings Center Report 39 (2):3-3.
  41.  10
    Lawrence Diller & Rebecca Dresser (forthcoming). Julia C. Spring Works for The. Hastings Center Report.
    No categories
    Direct download  
     
    Export citation  
     
    My bibliography  
  42.  12
    Rebecca Dresser (2006). Pharmaceutical Company Gifts: From Voluntary Standards to Legal Demands. Hastings Center Report 36 (3):8-9.
    Direct download (6 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  43.  9
    Larry R. Churchill & Rebecca Dresser (forthcoming). J. Andrew Billings is the Director. Hastings Center Report.
    Direct download  
     
    Export citation  
     
    My bibliography  
  44.  9
    Nancy Berlinger, Pauline W. Chen, Rebecca Dresser, Nancy Neveloff Dubler, Anne Lederman Flamm, Susan Gilbert, Mark A. Hall & Lisa H. Harris (forthcoming). Elizabeth Mitchell Armstrong is Asso. Hastings Center Report.
    Direct download  
     
    Export citation  
     
    My bibliography  
  45.  10
    Rebecca Dresser (2004). Plan B: Politics and Values at the FDA, Again. Hastings Center Report 34 (6):9-10.
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography  
  46.  5
    Rebecca Dresser (1997). Giving Scientists Their Due: The Imanishi‐Kari Decision. Hastings Center Report 27 (3):26-28.
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  47.  1
    Rebecca Dresser (2008). The Role of Patient Advocates and Public Representatives in Research. In Ezekiel J. Emanuel (ed.), The Oxford Textbook of Clinical Research Ethics. Oxford University Press 231.
    Direct download  
     
    Export citation  
     
    My bibliography   1 citation  
  48.  3
    Rebecca Dresser (2001). Payments to Research Participants: The Importance of Context. American Journal of Bioethics 1 (2):47.
    Direct download (6 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  49.  3
    Rebecca Dresser (1984). Bound to Treatment: The Ulysses Contract. Hastings Center Report 14 (3):13-16.
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography   3 citations  
  50.  8
    Rebecca Dresser (forthcoming). Advance Directives Implications for Policy. Hastings Center Report.
    Direct download  
     
    Export citation  
     
    My bibliography  
1 — 50 / 110